NINTEDANIB Zentiva caps moll 150 mg 60 pce

7680701240023 CH-70124 L01EX09 03.99.0.

Active substances:

No images available

Details

Product number
7012402
CPT
-
Packaging group
60
Unit
Kapsel(n)
Composition
nintedanibum 150 mg ut nintedanibi esilas 180.6 mg, triglycerida media, adeps solidus, polyglyceroli-3 dioleas, Kapselhülle: gelatina, glycerolum (85 per centum), E 171, E 172 (rubrum), E 172 (flavum), aqua purificata, Drucktinte: lacca, E 172 (nigrum), propylenglycolum, pro capsula.

Articles (1)

Nintedanib Zentiva 150 mg, Weichkapseln
Weichkapseln
60
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
22/12/2025
Patient information leaflet
Français
22/12/2025
Patient information leaflet
Italien
22/12/2025
Professional SmPC
Allemand
22/12/2025
Professional SmPC
Français
22/12/2025
Professional SmPC
Italien
22/12/2025

Detailed composition

Substance Quantity Type Category
nintedanibum
150.0 MG Substance Wirkstoff (Principe actif)
nintedanibi esilas
180.6 MG Substance WIZUS
triglycerida media
- Substance HNIDK
adeps solidus
- Substance HNIDK
polyglyceroli-3 dioleas
- Substance HNIDK
gelatina
- Substance HNIDK
glycerolum (85 per centum)
- Substance HNIDK
E 171
- Substance FNIDK
E 172 (rubrum)
- Substance FTODK
E 172 (flavum)
- Substance FTODK
aqua purificata
- Substance HNIDK
lacca
- Substance HNIDK
E 172 (nigrum)
- Substance FTODK
propylenglycolum
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)

Reimbursement information

Public price
CHF 355.15
Specialties list
Yes
Generic
Yes

Reimbursement limitation

SL addition date: 01/01/2026

Authorization holder

Helvepharm AG

8500 Frauenfeld

Authorization information

Swissmedic authorization number
70124
Drug name
Nintedanib Zentiva, Weichkapseln
Galenic form
KAPWE
ATC Code
L01EX09
Authorization status
Z
Dispensation category
B
First authorization
14/08/2025
Authorization expiration date
13/08/2030
IT number
03.99.0.
Domain
Human medicine
Field of application
Idiopathische Lungenfibrose, interstitielle Lungenerkrankungen

Packaging details

Description (FR)
NINTEDANIB Zentiva caps moll 150 mg 60 pce
Description (DE)
NINTEDANIB Zentiva Weichkaps 150 mg 60 Stk
Market launch
22/12/2025
Market withdrawal
28/08/2030
Narcotic (BTM)
No

Original drug

OFEV, Weichkapseln
CHF 1576.75
View original

Other packaging sizes

NINTEDANIB Zentiva caps moll 100 mg 60 pce
60 KAP
View
Buy us a coffee Explore the data